Application Notes: Pharmaceuticals
An Amino Acid Analysis According to European Pharmacopoeia 8.0
June 1st 2019The European Pharmacopoeia (Ph. Eur.) defi nes requirements for the qualitative and quantitative composition of medicines, as well as the tests to be carried out on medicines and on substances and materials used in their production.
Determination of Pharmaceuticals from Serum
December 1st 2018This application note describes the determination of pharmaceuticals from serum using solid-phase extraction (SPE) with the hydrophilic-lipophilic balanced SPE phase CHROMABOND® HLB for analyte enrichment and for sample cleanup. The eluates from SPE are finally analyzed by HPLC–MS/MS on a NUCLEOSHELL® PFP core–shell phase.
UHP-SEC Analysis of Biosimilars
September 1st 2018The amounts of high- and low-molecular-weight impurities are critical quality attributes for a therapeutic protein. Size-exclusion chromatography (SEC), the standard technology for analyzing aggregation and fragmentation, was applied to elucidate the molecular similarity between an Adalimumab biosimilar antibody and the corresponding innovator product Humira.
Determination of Pharmaceuticals from Serum
September 1st 2018This application note describes the determination of pharmaceuticals from serum using solid-phase extraction (SPE) with the hydrophilic-lipophilic balanced SPE phase CHROMABOND® HLB for analyte enrichment and for sample cleanup. The eluates from SPE are finally analyzed by HPLC–MS/MS on a NUCLEOSHELL® PFP core–shell phase